Fundraising Fox
Cirrus Therapeutics
Cambridge, US · 12 employees on LinkedIn · 1 known investors
Find your way into Cirrus Therapeutics
Sign up to find every way you can get introduced to Cirrus Therapeutics
- Your email: who you already know at Cirrus Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Cirrus Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Cirrus Therapeutics is a biotech developing gene and cell therapies based on ocular immunology to treat dry age-related macular degeneration (AMD), including an AAV gene therapy to restore the IRAK-M immune regulator and a next-generation retinal pigment epithelium (RPE) cell therapy for advanced geographic atrophy. It serves patients with chronic blinding eye diseases and operates from Cambridge, Massachusetts and Singapore.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Cirrus Therapeutics do?
- Cirrus Therapeutics is a biotech developing gene and cell therapies based on ocular immunology to treat dry age-related macular degeneration (AMD), including an AAV gene therapy to restore the IRAK-M immune regulator and a next-generation retinal pigment epithelium (RPE) cell therapy for advanced geographic atrophy. It serves patients with chronic blinding eye diseases and operates from Cambridge, Massachusetts and Singapore.
- Who founded Cirrus Therapeutics?
- Cirrus Therapeutics was founded by Ying Kai Chan.
- Who are Cirrus Therapeutics's investors?
- Cirrus Therapeutics's investors include ZAKA VC.
- Where is Cirrus Therapeutics headquartered?
- Cirrus Therapeutics is headquartered in Cambridge, US.